Diabetes drug testing in Europe

According to recent reports in the diabetes news, new clinical studies for a type 2 diabetes drug have started in the Netherlands. Initiated by Piramal Life Sciences Ltd, the oral drug will be tested on 72 volunteers.
Piramal submitted the clinical trial application (CTA) to the Netherlands regulatory board, the equivalent of the American Food and Drug Administration. Two panels approved the phase one clinical trials of the diabetic drug, the CCMO (Central Commission on Medical Research) and the BEBO (Independent Ethics Committee of the Foundation Evaluation of Ethics in Biomedical Research.)
Apparently, the results of the trials will be unveiled at the American Diabetes Association congress, which will be held in San Francisco in June. Piramal could create a novel treatment for type 2 diabetics .